# Hyperfine Swoop® System Introduced as India’s First Portable MRI for Bedside Brain Imaging at the Country’s Leading Medical Institution
Canonical URL: https://biopharmsignal.com/news/HYPR/hyperfine-swoopr-system-introduced-as-india-s-first-portable-mri-for-bedside-brain-imaging-at-the-country-s-leading-medical-institution
Ticker: HYPR
Company: Hyperfine
Source: Hyperfine
Published: 2026-04-29 12:15 EST
Original Source URL: https://investors.hyperfine.io
## Summary

The All India Institute of Medical Sciences, New Delhi, in partnership with Radiosurgery Global India, begins clinical use of the Hyperfine Swoop® portable MRI system NEW DELHI --(BUSINESS WIRE)--Apr. 29, 2026-- Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking health technology company that has

## Article Body
The All India Institute of Medical Sciences, New Delhi, in partnership with Radiosurgery Global India, begins clinical use of the Hyperfine Swoop® portable MRI system NEW DELHI --(BUSINESS WIRE)--Apr. 29, 2026-- Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking health technology company that has
## Recent Company News
- 2026-05-26 12:15 EST — [Hyperfine to Join Russell 2000® and Russell 3000® Indexes](https://biopharmsignal.com/news/HYPR/hyperfine-to-join-russell-2000r-and-russell-3000r-indexes) — Source: Hyperfine
- 2026-05-22 12:15 EST — [Hyperfine Announces Presentation of Results from the PRIME Study Showing Portable MRI Substantially Reduces Time to Imaging in Emergency Departments](https://biopharmsignal.com/news/HYPR/hyperfine-announces-presentation-of-results-from-the-prime-study-showing-portable-mri-substantially-reduces-time-to-imaging-in-emergency-departments) — Source: Hyperfine
- 2026-05-12 20:05 EST — [Hyperfine, Inc. Reports First Quarter 2026 Financial Results](https://biopharmsignal.com/news/HYPR/hyperfine-inc-reports-first-quarter-2026-financial-results) — Source: Hyperfine
- 2026-05-06 20:05 EST — [Hyperfine, Inc. to Participate in Upcoming 2026 Jefferies Global Healthcare Conference](https://biopharmsignal.com/news/HYPR/hyperfine-inc-to-participate-in-upcoming-2026-jefferies-global-healthcare-conference) — Source: Hyperfine
- 2026-04-29 12:15 EST — [Hyperfine Swoop® System Introduced as India’s First Portable MRI for Bedside Brain Imaging at the Country’s Leading Medical Institution](https://biopharmsignal.com/news/HYPR/hyperfine-swoopr-system-introduced-as-india-s-first-portable-mri-for-bedside-brain-imaging-at-the-country-s-leading-medical-institution) — Source: Hyperfine
## Related News
- 2026-07-22 20:05 EST — AZTA — [Azenta Announces Fiscal 2026 Third Quarter Conference Call and Webcast](https://biopharmsignal.com/news/AZTA/azenta-announces-fiscal-2026-third-quarter-conference-call-and-webcast-48419fff)
- 2026-07-22 20:05 EST — VKTX — [Viking Therapeutics to Report Financial Results for Second Quarter 2026 on July 29, 2026](https://biopharmsignal.com/news/VKTX/viking-therapeutics-to-report-financial-results-for-second-quarter-2026-on-july--bbf2553f)
- 2026-07-22 20:01 EST — AXON — [Axon to Release Second Quarter 2026 Earnings on August 5, 2026](https://biopharmsignal.com/news/AXON/axon-to-release-second-quarter-2026-earnings-on-august-5-2026-66120902)
- 2026-07-22 12:39 EST — ARTL — [New Analysis of Over 50 Studies Showed that All the Non-Prescription CBD Products Researched Fell Short of Therapeutic Efficacy — Reinforcing the Case for Artelo's Optimized ART12.11 CBD Composition](https://biopharmsignal.com/news/ARTL/new-analysis-of-over-50-studies-showed-that-all-the-non-prescription-cbd-product-a3445432)
- 2026-07-22 12:30 EST — NRSN — [NeuroSense Advances PrimeC Toward New Drug Submission to Health Canada for ALS](https://biopharmsignal.com/news/NRSN/neurosense-advances-primec-toward-new-drug-submission-to-health-canada-for-als-721c198c)
